Summary:
- The article discusses a study that aimed to develop and validate a risk prediction model called AIMS65 to predict the risk of mortality and rebleeding in patients with gastrointestinal (GI) bleeding who have received treatment.
- The AIMS65 model considers five factors: Albumin level, International Normalized Ratio (INR), altered mental status, systolic blood pressure, and age over 65 years, to assess the risk of in-hospital mortality and rebleeding in GI bleed patients.
- The study found that the AIMS65 model demonstrated good accuracy in predicting the risk of in-hospital mortality and rebleeding, and it could be a useful tool for clinicians to stratify the risk and guide treatment decisions for patients with GI bleeding.